Cited by 315Bone health and osteoporosis researchBone Metabolism and DiseasesSpaceflight effects on biology

Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss

Gaudio, Agostino, Pennisi, Pietra, Bratengeier, Cornelia, Torrisi, Venerando, Lindner, Brigitte, Mangiafico, Roberto A., Pulvirenti, Ivana, Hawa, Gerhard +2 more·2010·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Sclerostin, a Wnt signaling antagonist on the osteoblasts produced by osteocytes, is regulated by mechanical strain and is implicated in the pathogenesis of disuse bone loss. There are no data on sclerostin in humans. Objective: The aim of the study was to evaluate sclerostin in patients immobilized after stroke, compared with control subjects, and to analyze its relationship with markers of bone formation and resorption. Design: This was a cross-sectional study. Setting and patients: We studied 40 postmenopausal women immobilized after a single episode of stroke 6 months or longer after onset, and 40 postmenopausal women from the general community. Bone status was assessed by quantitative ultrasound measurements at the calcaneus. Bone alkaline phosphatase (b-AP), carboxy-terminal telopeptide of type I collagen (CrossLaps), and sclerostin were evaluated by ELISA. We also used ELISA to measure serum levels of Dickkopf-1, another soluble inhibitor of Wnt/β-catenin signaling, highly expressed by osteocytes. Results: Immobilized patients had higher sclerostin serum levels (median 0.975 ng/ml; 25th to 75th percentiles 0.662–1.490) than controls (median 0.300 ng/ml; 25th to 75th percentiles 0.165–0.400: P < 0.0001) and an increased bone turnover with a more significant rise in bone resorption (CrossLaps) than formation (b-AP) markers. Sclerostin correlated negatively with b-AP (r = −0.911; P < 0.0001) and positively with CrossLaps (r = 0.391; P = 0.012). Dickkopf-1 did not significantly differ between the groups. Patients also had quantitative ultrasound measurements index lower than controls (P < 0.001). Conclusions: This study shows for the first time that long-term immobilized patients present hypersclerostinemia associated with reduced bone formation, and suggests that sclerostin could be a link between mechanical unloading and disuse osteoporosis in humans.

Integrity signals

Registry

Crossref · 10.1210/jc.2010-0067

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mechanical unloading downregulates anabolic factors and stimulates osteocytes to produce sclerostin and DKK-1 (inhibitors of osteoblast activity) and factors that stimulate local osteoclastogenesis.

    “On the other hand, mechanical unloading downregulates anabolic factors and stimulates osteocytes to produce sclerostin and DKK-1, which are inhibitors of osteoblast activity [185–188], as well as specific factors that stimulate local osteoclastogenesis [189].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gaudio, A., Pennisi, P., Bratengeier, C., Torrisi, V., Lindner, B., Mangiafico, R. A., Pulvirenti, I., Hawa, G., Tringali, G., & Fiore, C. E.
Affiliations
  • University of Catania (IT)
  • Biomarker Design Forschungs GmbH (C.B., B.L., G.H.), A-1210 Wien, Austria
  • Istituto Ricerca Medica Ambientale (V.T., G.T.), 95024 Acireale, Italy
Corresponding author
Fiore, Carmelo E.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2010-05-01
Volume
95
Issue
5
Pages
2248-2253
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2080784991
Cited by
315
References
38
Citations by year
2026: 6 · 2025: 8 · 2024: 6 · 2023: 15 · 2022: 22 · 2021: 19 · 2020: 18 · 2019: 15 · 2018: 10 · 2017: 16 · 2016: 12 · 2015: 23 · 2014: 29 · 2013: 39 · 2012: 31
FWCI
36.76
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Physiology › Spaceflight effects on biology
Keywords
sclerostin, disuse osteoporosis, stroke, bone formation markers, bone resorption markers, DKK1, Wnt/β-catenin signaling, osteocytes, mechanical unloading, postmenopausal women, quantitative ultrasound, bone turnover
MeSH terms
Aged, Aged, 80 and over, Bone Development, Bone Resorption, Coronary Disease, Cross-Sectional Studies, Depression, Diabetes Mellitus, Female, Genetic Markers, Humans, Immobilization, Osteoblasts, Osteocytes, Paresis, Reference Values, Body Mass Index, Postmenopause, Bone Morphogenetic Proteins, Stroke, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review